GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAEL Revenue

GemVax&KAEL had revenue of 22.71B KRW in the quarter ending June 30, 2026, a decrease of -9.24%. This brings the company's total for the last twelve months to 85.10B, up 24.42% year-over-year. In the year 2025, GemVax&KAEL had annual revenue of 81.53B with 30.05% growth. That makes GemVax&KAEL the 26,172nd largest company in the world by revenue and 1,549th in South Korea.

• Revenue (ttm): 85.10B
• Revenue Growth: +24.42%
• P/S Ratio: 4.23
• Revenue / Employee: 421.30M
• Employees: 202
• Market Cap: 376.69B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Environmental Pollution Control Division 70.03B 85.9%
• Bio Division 11.50B 14.1%

By Geography

Chart

• Korea 56.86B 81.2%
• China 6.60B 9.4%
• Japan 3.32B 4.7%
• Southeast Asia 2.92B 4.2%
• United States of America 334.08M 0.5%

Fiscal year ended Dec 31, 2025 See the full GemVax&KAEL breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	81.53B	18.84B	30.05%
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error